In a disconcerting display at the National Institutes of Health Clinical Center in Bethesda, Maryland, on Thursday, President Joe Biden once again demonstrated his lack of clarity on pressing issues. While he announced a mandate for pharmaceutical companies to issue rebates to Medicare for drug price hikes, his delivery was muddled and bewildering.
Even closed captioning can’t keep up with him
— Rob Coates 🇺🇸 (@LuckyHippie926) December 14, 2023
At a critical juncture when Americans are desperately seeking relief from skyrocketing prescription drug costs, Biden’s convoluted statements only exacerbated uncertainties. This latest incident of incoherence is particularly alarming, as it directly impacts the lives of those dependent on these medications.
The final quarter of 2023 witnessed an alarming trend where 48 Medicare Part B drugs saw prices surge beyond inflation rates. Although some increases might be attributed to the year’s inflation, Biden’s inability to communicate effectively about such a vital topic has left many concerned about his competency in addressing these issues.
Dubbed “Sleepy Joe” by critics, Biden’s tenure in the White House has been marred by a series of verbal blunders and ambiguous statements, raising serious doubts about his leadership abilities. His recent appearance at the NIH, far from providing clarity and direction, has only added to the growing list of his inadequacies as President.